Risk of genital and urinary tract infections associated with SGLT‐2 inhibitors as an add‐on therapy to metformin in patients with type 2 diabetes mellitus: A retrospective cohort study in Korea

Risk of genital and urinary tract infections associated with SGLT‐2 inhibitors as an add‐on therapy to metformin in patients with type 2 diabetes mellitus: A retrospective cohort study in Korea

Abstract Sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors are antidiabetic drugs with associated safety concerns regarding the risk of genital and urinary tract infections. This study assessed the risk of genital and urinary tract infections associated with prescription of SGLT‐2 inhibitors as an...

Full description

Bibliographic Details
Main Authors: Hyeri Yang, Eunmi Choi, Eunjun Park, Eonji Na, Soo Youn Chung, Bonggi Kim, Soon Young Han
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Pharmacology Research & Perspectives
Subjects:
genital infection
SGLT‐2 inhibitors
type 2 diabetes mellitus
urinary tract infection
Online Access:https://doi.org/10.1002/prp2.910

Similar Items

Similar Items